Last reviewed · How we verify

ICG R15 — Competitive Intelligence Brief

ICG R15 (ICG R15) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Near-infrared fluorescent contrast agent. Area: Surgery/Hepatology.

marketed Near-infrared fluorescent contrast agent Surgery/Hepatology Small molecule Live · refreshed every 30 min

Target snapshot

ICG R15 (ICG R15) — Seoul National University Hospital. ICG R15 is an indocyanine green (ICG) derivative that fluoresces in the near-infrared spectrum for real-time visualization of liver function and blood flow during surgery.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ICG R15 TARGET ICG R15 Seoul National University Hospital marketed Near-infrared fluorescent contrast agent
Indocyanine Green Drug Indocyanine Green Drug Theodor Bilharz Research Institute marketed Near-infrared fluorescent contrast agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Near-infrared fluorescent contrast agent class)

  1. Seoul National University Hospital · 1 drug in this class
  2. Theodor Bilharz Research Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ICG R15 — Competitive Intelligence Brief. https://druglandscape.com/ci/icg-r15. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: